Lab Information
Talat Bessissow (MD/MSc)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Crohn's disease • ulcerative colitis • mucosal healing • neoplasia • pathogenesisResearch Interests
My research focuses on the role of mucosal healing in the treatment of inflammatory bowel diseases. I am also looking at identifying factor that predict disease relapse.Team Members
| Name | Position |
|---|
Latest Publications
- Li Fraine, S., Marcus, V., Kron, C. M., Lakatos, P. L., Afif, W., Bitton, A., Wild, G. & Bessissow, T. (2025). Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis. Journal of clinical medicine, vol. 14.
- Shehab, M., Alrashed, F., Alrashidi, A., Hassan, A., Ma, C., Narula, N., Jairat, V., Regueiro, M. & Bessissow, T. (2025). Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease. Alimentary pharmacology & therapeutics.
- AlBader, B., Jairath, R., Baitalmal, H. & Bessissow, T. (2025). Upadacitinib for the Treatment of Upper Gastrointestinal Crohn's Disease. ACG case reports journal, vol. 12, p. e01749.
- Al Alawi, S., Bessissow, T., Fallone, C. A., Jacques, J. & Barkun, A. (2025). Hemostatic powder's battle against a spurting bleeding ulcer: can it win?. Endoscopy, vol. 57, p. E676-E677.
- De Marco, D., Heron, V., Bitton, A., Bessissow, T., Lakatos, P., Wild, G. & Afif, W. (2025). Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study. Journal of the Canadian Association of Gastroenterology, vol. 8, p. 97-102.
- Solitano, V., Ogunsakin, R. E., Yuan, Y., Bernstein, C. N., Bessissow, T., Bressler, B., Hoentjen, F., van Lierop, L., Leung, Y., MaMD, C., Marshall, J. K., Narula, N., Alahmari, M., Mccurdy, J. D., Murthy, S., Panaccione, R., Rosenfeld, G., Milgrom, R., Silverberg, M. & Jairath, V. (2025). Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study. The American journal of gastroenterology.
- McCurdy, J. D., Macdonald, B., Rosenfeld, G., Bessissow, T., Jairath, V., Bruining, D. H. & Singh, S. (2025). Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary pharmacology & therapeutics, vol. 61, p. 1959-1960.
- McCurdy, J. D., Macdonald, B., Rosenfeld, G., Bessissow, T., Jairath, V., Bruining, D. H. & Singh, S. (2025). Letter: Re-Examining Seton Efficacy in Perianal Crohn's Disease-Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply. Alimentary pharmacology & therapeutics, vol. 61, p. 1971-1972.
- Alenezi, A. F., Jahrami, H., Kanber, Y. & Bessissow, T. (2025). Gastrointestinal Tract Perineuriomas and Benign Fibroblastic Polyps: Case Report and Comprehensive Systematic Review. Case reports in gastrointestinal medicine, vol. 2025, p. 1636142.
- Angyal, D., Balogh, F., Bessissow, T., Wetwittayakhlang, P., Ilias, A., Gonczi, L. & Lakatos, P. L. (2025). The Role of Histology Alongside Clinical and Endoscopic Evaluation in the Management of IBD-A Narrative Review. Journal of clinical medicine, vol. 14.
See also
